These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12403231

  • 1. Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia.
    Kankirawatana S, Veerakul G, Sanpakit K, Tanphaichitr VS, Akkabutr P, Suwantol L, Mahasandana C.
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S549-57. PubMed ID: 12403231
    [Abstract] [Full Text] [Related]

  • 2. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM, Hop WC, van Kessel-Bakvis C, Stigter R, Pieters R.
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [Abstract] [Full Text] [Related]

  • 3. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
    Totan M, Dagdemir A, Ak AR, Albayrak D, Kucukoduk S.
    Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
    [Abstract] [Full Text] [Related]

  • 4. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A, Mann G, Kronberger M, Witt V, Gadner H, Dworzak M.
    Klin Padiatr; 2003 Apr; 215(6):321-6. PubMed ID: 14677096
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
    Sutor AH, Mall V, Thomas KB.
    Klin Padiatr; 1999 Apr; 211(4):201-4. PubMed ID: 10472550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
    McLean TW, Fisher CJ, Snively BM, Chauvenet AR.
    J Clin Oncol; 2005 May 01; 23(13):3024-9. PubMed ID: 15860859
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
    Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G.
    Pediatr Blood Cancer; 2007 Jan 01; 48(1):21-7. PubMed ID: 16317756
    [Abstract] [Full Text] [Related]

  • 16. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
    Indiano JM, Echaniz I, Humayor J, Delgado A.
    An Esp Pediatr; 1988 Oct 01; 29 Suppl 34():94-8. PubMed ID: 3214047
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.